Urologix
Urologix is a Minnesota-based medical device company that manufactures and sells in-office BPH treatment systems — Cooled ThermoTherapy (microwave) and Prostiva RF Therapy — directly to US urologists and their practices.
- Company typePrivate
- Founded1991
- HeadquartersMinneapolis, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Urologix does
Urologix, founded in 1991 and headquartered in Plymouth, Minnesota, is a medical device company that develops, manufactures, and sells minimally invasive, in-office systems for the treatment of benign prostatic hyperplasia (BPH). The company operates two core technology platforms: Cooled ThermoTherapy™ (CTT), a transurethral microwave thermotherapy (TUMT) system that delivers targeted microwave energy through a catheter while circulating cooling fluid to protect urethral tissue and maintain urethral temperatures at or below 40°C while reaching intraprostatic temperatures near 80°C; and Prostiva® RF Therapy, a transurethral needle ablation (TUNA) system that uses low-level radio frequency energy delivered through needle electrodes to coagulate enlarged prostate tissue at intraprostatic temperatures of approximately 110°C. Supporting components include the CoolWave and Targis control units, the CTC Advance catheter family in three lengths, the Rectal Thermal Sensing Unit with five thermosensors, and for Prostiva, an RF generator with touch-screen controls, a single-use hand piece, and reusable telescopes available in 0° and 15° angles. The Prostiva generator monitors urethral and prostatic temperatures six times per second, controls RF power 5,000 times per second, and measures impedance and power 50 million times per second, with 15 computer-monitored safety checks.
The company's commercial model is built around direct, US-only sales to urologists and urology practices through a field sales force supported by a customer service organization and a website-based physician locator. Revenue is generated primarily from hardware sales of control units and from recurring single-use procedure kits, catheters, and treatment components consumed during each in-office BPH procedure. Both treatments are performed in-office in under an hour without general anesthesia, are covered by Medicare across all 50 states and by most private insurers, and are positioned against long-term BPH medications and surgical interventions. Urologix markets to both patients (via educational content, seminars, testimonials, and media appearances) and clinicians (via a clinician resource library, the 'Urologic Highlights in Men's Health' newsletter, and clinical publications), and also operates a Mobile Services channel that brings equipment into practices that lack in-house capital.
Clinically, Urologix reports that Cooled ThermoTherapy has been used to treat over 225,000 men and Prostiva RF Therapy over 100,000 patients worldwide, supported by nearly 200 peer-reviewed clinical articles and presentations since 1991 across more than 50 centers. The company cites durable outcomes of over 90% reintervention-free at five years for CTT and over 86% for Prostiva, with symptom improvement typically reported within 6-12 weeks. The patient target population is men with moderate to severe lower urinary tract symptoms caused by BPH, and the immediate customer is the practicing urologist performing the in-office procedure.
Urologix firmographics
Firmographics- Name
- Urologix
- Legal name
- Urologix, LLC
- Website
- https://urologix.com
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Urologix is a Minnesota-based medical device company that manufactures and sells in-office BPH treatment systems — Cooled ThermoTherapy (microwave) and Prostiva RF Therapy — directly to US urologists and their practices.
- Ownership category
- akta.pro rank
Urologix industry classification
Industry- Product category
- Urology Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF)
- akta.pro secondary industries
- General Urology (HLAKAOAA), Nephrology & Urology Specialty Pharmaceuticals (HLAIACAH)
Keywords
Where Urologix is headquartered
LocationHeadquarters
- HQ city
- Minneapolis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Urologix business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Medical Device Sales: Urologix generates revenue through the sale of its Cooled ThermoTherapy and Prostiva RF Therapy medical device systems, including control units, catheters, and related consumables to urologists and healthcare providers.
- Procedure Kits and Consumables: Sale of single-use procedure kits, catheters, and treatment components that are consumed during BPH procedures performed in urologists' offices.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Medicare coverage for BPH procedures |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Urologix product offering
Product offeringCore offering
Urologix manufactures and distributes minimally invasive medical device systems for the in-office treatment of benign prostatic hyperplasia (BPH). The company sells two primary therapy platforms — Cooled ThermoTherapy (CTT), which uses transurethral microwave energy with proprietary urethral cooling, and Prostiva RF Therapy, which uses low-level radio frequency energy delivered via needle electrodes — along with the associated control units, catheters, and consumable procedure kits sold to urologists and urology practices.
Product overview
Urologix offers a portfolio of medical devices for in-office treatment of Benign Prostatic Hyperplasia (BPH). The company's core products are Cooled ThermoTherapy™ (CTT) using microwave technology and Prostiva® RF Therapy using radio frequency energy. Both are minimally invasive, non-surgical procedures performed in a urologist's office in under an hour without general anesthesia. The Cooled ThermoTherapy system includes the CoolWave or Targis Control Units, CTC Advance Microwave Catheters (in Short, Standard, and Long sizes), Rectal Thermal Sensing Unit, and Coolant Bag. The Prostiva RF system includes a Generator, Hand Piece, and Telescope. These products provide long-term relief from BPH symptoms with clinically proven durability lasting up to 5 years.
Differentiator
Problem solved
Functional benefit
Brands
- Cooled ThermoTherapy™: A safe, effective, in-office BPH treatment that provides long-term relief from BPH symptoms using microwave energy with advanced urethral cooling system.
- Prostiva® RF Therapy
Products and services
- Cooled ThermoTherapy™ (CTT) A safe, effective in-office treatment for benign prostatic hyperplasia (BPH) that uses microwave energy delivered via a transurethral catheter to heat and reduce excess prostate tissue while circulating cooling fluid to protect the urethra and maintain patient comfort. Performed in a urologist's office in under an hour without general anesthesia, for men suffering lower urinary tract symptoms.
- Prostiva® RF Therapy A safe, effective in-office treatment for BPH that uses low-level radio frequency energy delivered via needles placed directly into the prostate to generate heat and cause coagulation of excess tissue, relieving urethral constriction. Known as Transurethral Needle Ablation (TUNA), the procedure is performed in a urologist's office in under an hour without general anesthesia.
Quantifiable outcome
- Over 90% of Cooled ThermoTherapy patients require no reintervention at 5 years
- +4 more outcomes
Companies that use Urologix
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Urologix technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Urologix partnerships and signals
Strategic signalScale indicators7 records
Recent moves2 records
Expansion highlights3 records
Urologix competitors and assessment
Company assessmentBroad incumbents
- Olympus Corporation: Olympus is a major urology device manufacturer offering resectoscopes, laser systems, and other BPH surgical solutions; competes with Urologix in the broader BPH treatment category though typically in hospital settings.
- Stryker Corporation: Stryker is a diversified medical device company with surgical and urology portfolios; while not a direct competitor to Urologix's TUMT/TUNA products, it represents a broad incumbent that could expand into office-based BPH therapies.
- KARL STORZ: KARL STORZ produces urological endoscopy and surgical instruments including BPH treatment equipment, representing a broader incumbent competing with Urologix's specialized in-office microwave and RF systems.
- Richard Wolf: Richard Wolf manufactures urology surgical instruments and BPH resection devices, overlapping with Urologix's endourology and minimally invasive urology focus from a hospital-based incumbent angle.
Emerging players
- AngioDynamics: AngioDynamics has explored prostate artery embolization as a minimally invasive BPH treatment, representing an emerging alternative therapy modality that competes with Urologix's in-office thermal approaches.
Direct peers
- PROCEPT BioRobotics: PROCEPT BioRobotics manufactures the Aquablation system for BPH treatment, an emerging robotically-assisted minimally invasive therapy competing with Urologix's in-office BPH offerings.
- Boston Scientific (Rezum): Boston Scientific acquired NxThera and sells the Rezum system, a water vapor thermal therapy for BPH that competes head-to-head with Urologix's TUMT and TUNA platforms in urology offices.
- Teleflex (NeoTract/UroLift): Teleflex acquired NeoTract and markets the UroLift system for in-office BPH treatment, directly competing with Urologix's Cooled ThermoTherapy and Prostiva RF Therapy in the same physician office setting.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Urologix social profiles
Digital presenceUrologix financial estimates
Financial estimateRevenue estimate
Valuation estimate
Urologix leadership team
Management profileNumber of profiles
Profiles3 records
Urologix funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Urologix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Urologix
What does Urologix do?
Urologix manufactures and distributes minimally invasive medical device systems for the in-office treatment of benign prostatic hyperplasia (BPH). The company sells two primary therapy platforms — Cooled ThermoTherapy (CTT), which uses transurethral microwave energy with proprietary urethral cooling, and Prostiva RF Therapy, which uses low-level radio frequency energy delivered via needle electrodes — along with the associated control units, catheters, and consumable procedure kits sold to urologists and urology practices.
Is Urologix a public or private company?
Urologix is a private company. It is classified as public and is currently operating.
When was Urologix founded?
Urologix was founded in 1991. It employs 251 to 500 people.
Where is Urologix based?
Urologix is headquartered in Minneapolis, United States, in the North America region.
How does Urologix make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are procedure Kits and Consumables.
Who are Urologix's main competitors?
Broad incumbents on record are Olympus Corporation, Stryker Corporation, KARL STORZ and Richard Wolf. AngioDynamics is listed as an emerging player. Direct peers are PROCEPT BioRobotics, Boston Scientific (Rezum) and Teleflex (NeoTract/UroLift).
Does Urologix have an API?
No public API is recorded for Urologix.
What industry is Urologix in?
Urologix's product category is Urology Medical Devices. Its primary akta.pro industry code is HLAKAOAF, Endourology & Minimally Invasive Urologic Surgery, with a secondary code of HLAKAOAA, General Urology. Its NAICS code is 334510 and its SIC code is 3841.